Next, we found that mutations in MEN1, PTEN and ATRX or DAXX co-occur with a high statistical likelihood, suggesting that co-mutation of those genes is one of the core determinants of pancreatic neuroendocrine tumors pathogenesis (Fig. 1B). The gene discussed is PTEN; the disease is pancreatic neuroendocrine tumor.